Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of September 2023, with a specific report date of September 5, 2023. The filing serves to disclose a material corporate event regarding regulatory approval for the Company's ProSense Cryoablation System in Brazil.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the receipt of regulatory approval in Brazil for the Company's ProSense Cryoablation System. This approval expands the Company's potential market access in Latin America.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward Looking Statements" section from the accompanying press release (Exhibit 99.1). The text does not explicitly detail specific financial guidance, management commentary on future performance, or a list of risks within the body of this Form 6-K, deferring to the referenced press release for such information.
Investor Verification Checklist
- Verify the specific scope and limitations of the regulatory approval granted in Brazil for the ProSense Cryoablation System.
- Review the full text of the press release (Exhibit 99.1) for detailed forward-looking statements and risk factors.
- Confirm the timeline for commercial launch and reimbursement status in the Brazilian market.
- Check subsequent filings for any updates on the commercialization strategy in Brazil.